Life Science
Several active substances/medicines have to be released continuously over a long period of time or have to be delivered specifically to the site of action. This is necessary in order to achieve the best possible effect or to reduce possible side effects. Surflay develops drug delivery systems. We are also engaged in the coating of medical devices (e.g. stents).
Projects
ParOptiSense
Entwicklung partikelbasierter optischer Sensoren für die Echtzeitanalyse von Stoffwechselvorgängen für In-vitro-Testsysteme.
Partner:
•Fraunhofer IZI-BB, Potsdam
Funding agencies: Projektträger Jülich (PTJ) (BMBF: 031B0763A)
Project duration: 01.04.2019 - 31.03.2022
LipoLens
Ein neuartiges liposomales System zur Medikamentenverabreichung durch Kontaktlinsen.
Partner:
•Fraunhofer IAP, Potsdam
•Universitätsklinikum Rostock, Rostock
•DendroPharm GmbH, Berlin
•Weizmann Institute of Science, Rechovot, Israel
•EyeYon Medical Ltd., Ness Ziona, Israel
Funding agencies: Deutsches Zentrum für Luft- und Raumfahrt (DLR) (BMBF: 01IO1804)
Project duration: 01.06.2018 - 31.05.2021
ImmunoPlex
Surflay's WhisperSense technology is used and further developed for a reliable and cost-efficient screening of auto-immune diseases in samples.
Partner:
•Diarect AG, Freiburg
•Scienion AG, Berlin
Funding agencies: Projektträger Jülich (PTJ) (BMWi: 031B0498A)
Project duration: 01.03.2018 - 28.02.2021
